Sai Parenteral’s IPO Details
Sai Parenteral’s IPO Deatils : GMP, Subscription, Date
- 📄 IPO Details
- 📊 IPO Subscribe
- 📅 Important Date
- 📈 Day Wise Gmp
- 🧮 Day Wise Subscribe
- 📦 Ipo Lot Size
- 🏷️ Ipo Reservation
- 🏢 About Company
- 🎯 Objective of Ipo
- 🚀 Financial Report
Ipo Details
| Attribute | Details |
|---|---|
| IPO Date | 24 to 27 Mar, 2026 |
| Listing Date | Thu, Apr 2, 2026 |
| Face Value | ₹5 per share |
| Price Band | ₹372 to ₹392 |
| Lot Size | 38 Shares |
| Sale Type | Fresh capital cum OFS |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Total Issue Size | 1,04,28,288 shares (agg. up to ₹409 Cr) |
| Fresh Issue | 72,70,408 shares (agg. up to ₹285 Cr) |
| Offer for Sale | 31,57,880 shares of ₹5 (agg. up to ₹124 Cr) |
| Share Holding Pre Issue | 3,69,08,823 shares |
| Share Holding Post Issue | 4,41,79,231 shares |
Subscription
| QIB | 1.73x |
| NII | 2.45x |
| Retail | 0.12x |
| Total | 1.08x |
Important Date
| Event | Date |
|---|---|
| IPO Open | Tue, Mar 24, 2026 |
| IPO Close | Fri, Mar 27, 2026 |
| Allotment | Mon, Mar 30, 2026 |
| Refund | Wed, Apr 1, 2026 |
| Credit of Shares | Wed, Apr 1, 2026 |
| Listing | Thu, Apr 2, 2026 |
Day Wise Gmp
| Date | Price | GMP | Sub | Est Price | Profit | Updated |
|---|---|---|---|---|---|---|
| 02-04-2026 | ₹392.00 | ₹0.00 — | 1.08 | ₹392.00 | ₹0.00 | 00:12 |
| 01-04-2026 | ₹392.00 | ₹0.00 — | 1.08 | ₹392.00 | ₹0.00 | 00:33 |
| 30-03-2026 | ₹392.00 | ₹0.00 — | 1.08 | ₹392.00 | ₹0.00 | 23:53 |
| 29-03-2026 | ₹392.00 | ₹0.00 — | 1.08 | ₹392.00 | ₹0.00 | 23:55 |
| 28-03-2026 | ₹392.00 | ₹0.00 — | 1.08 | ₹392.00 | ₹0.00 | 23:45 |
| 27-03-2026 | ₹392.00 | ₹0.00 — | 1.02 | ₹392.00 | ₹0.00 | 23:43 |
| 26-03-2026 | ₹392.00 | ₹0.00 — | 0.40 | ₹392.00 | ₹0.00 | 00:26 |
| 25-03-2026 | ₹392.00 | ₹0.00 — | 0.05 | ₹392.00 | ₹0.00 | 00:23 |
| 23-03-2026 | ₹392.00 | ₹0.00 — | 0.00 | ₹392.00 | ₹0.00 | 23:40 |
Day Wise Subscribe
| Date | QIB | NII | Retail | Total |
|---|---|---|---|---|
| 29 Mar | 1.73x | 2.45x | 0.12x | 1.08x |
| 28 Mar | 1.73x | 2.45x | 0.12x | 1.08x |
| 27 Mar | 1.73x | 2.2x | 0.11x | 1.02x |
| 26 Mar | 0.6x | 1.05x | 0.05x | 0.42x |
| 25 Mar | - | 0.15x | 0.03x | 0.05x |
Ipo Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 38 | ₹14,896 |
| Retail (Max) | 13 | 494 | ₹1,93,648 |
| S-HNI (Min) | 14 | 532 | ₹2,08,544 |
| S-HNI (Max) | 67 | 2,546 | ₹9,98,032 |
| B-HNI (Min) | 68 | 2,584 | ₹10,12,928 |
Ipo Reservation
| Investor Category | Shares Offered |
|---|---|
| QIB Shares Offered | Not more than 50% of the Net Offer |
| Retail Shares Offered | Not less than 35% of the Net Offer |
| NII (HNI) Shares Offered | Not less than 15% of the Net Offer |
About Company
About Sai Parenteral's Ltd.
2001 mein sthapit (incorporated), Sai Parenteral's Ltd. ek diversified pharmaceutical formulations company hai jise research, development, aur manufacturing mein maharat haasil hai. Company mukhya roop se do segments mein kaam karti hai: Branded Generic Formulations aur Contract Development and Manufacturing Organisation (CDMO) products, jo domestic aur international dono markets ke liye hain.
Company ka product portfolio kai therapeutic areas ko cover karta hai, jaise cardiovascular, neuropsychiatry, anti-diabetic, respiratory health, antibiotics, gastroenterology, vitamins, minerals, aur dermatology. Inke products injectables, tablets, capsules, liquid orals, aur ointments aadi forms mein uplabdh hain.
Bharat mein inke grahakon (customers) mein central aur state government agencies, pharma companies, private aur public hospitals shamil hain. FY 2023 mein inhone Hyderabad mein internationally accredited facilities acquire karke exports shuru kiye, aur ab yeh Australia, New Zealand, Southeast Asia, Middle East, aur Africa ko bhi supply karte hain.
Competitive Strengths (Company ki Takat):
- Established track record ke sath diversified generic formulations player.
- Behtarin locations par sthit aur accredited Manufacturing Facilities.
- CDMO business par majboot focus.
- Bharat aur videsh mein well-established distribution network.
- Experienced Promoters aur Senior Management.
Objective of Ipo
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Capacity expansion and upgradation of manufacturing facilities | 110.80 |
| 2 | Establishment of a new R&D Centre | 18.02 |
| 3 | Repayment / prepayment of certain outstanding borrowings | 14.30 |
| 4 | Working capital requirements | 33.00 |
| 5 | Investment in wholly owned subsidiary, Sai Parenterals Pte Limited (Singapore) | 35.64 |
| Total | 211.76 |
Financial Report
| Period Ended | 30 Sep 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets | 376.24 | 272.39 | 268.10 | 133.96 |
| Total Income | 89.43 | 163.74 | 155.18 | 97.03 |
| Profit After Tax | 7.76 | 14.43 | 8.42 | 4.38 |
| EBITDA | 16.24 | 39.44 | 31.70 | 17.64 |
| NET Worth | 209.37 | 95.78 | 76.40 | 31.49 |
| Reserves and Surplus | 188.84 | 80.36 | 61.30 | 24.34 |
| Total Borrowing | 76.07 | 93.95 | 118.79 | 68.55 |
